Benzoic acid, 2-hydroxy-, (3Z)-1-methyl-3-hexen-1-yl ester
Common Name: |
Benzoic acid, 2-hydroxy-, (3Z)-1-methyl-3-hexen-1-yl ester |
IUPAC Name: |
[(Z)-hept-4-en-2-yl] 2-hydroxybenzoate |
Molecular Formula: |
C14H18O3 |
SMILES: |
CCC=CCC(C)OC(=O)C1=CC=CC=C1O |
Inchi: |
1S/C14H18O3/c1-3-4-5-8-11(2)17-14(16)12-9-6-7-10-13(12)15/h4-7,9-11,15H,3,8H2,1-2H3/b5-4- |
Inchi Key: |
AWFJMMINHWORIB-PLNGDYQASA-N |
Cas No: |
873888-84-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
234.29 |
Mass (g/mol) |
234.126 |
Molar Refractivity |
68.11 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
46.53 |
Hetero Atoms |
3 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
324.94 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.36 |
LogP |
3.294 |
iLOGP |
3.28 |
XLOGP3 |
4.75 |
WLOGP |
3.29 |
MLOGP |
2.96 |
ESOL Log S |
-4.15 |
ESOL Solubility (mg/ml) |
0.017 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.46 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.24 |
Silicos-IT Solubility (mg/ml) |
0.14 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.36 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.1 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.201 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |